Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Eureka Therapeutics Logo
Eureka Therapeutics Growth Score
29
CB Rank
33710
Heat Score
50
Eureka Therapeutics is a biotechnology company that develops T-cell therapies.
Founded
obfuscation
PrivateGrant Emeryville, California, United States51-100 www.eurekatherapeutics.com
Biotechnology
Health Care
Medical
Therapeutics
Overview

Eureka Therapeutics
Total Funding
obfuscation
Growth Score
29
Heat Score
50

Total Funding
obfuscation
obfuscation
Grant raised
obfuscation
Growth Score29
-39 pts
in past quarter
Heat Score 50
-9 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Eureka Therapeutics

CB Rank
33710
Eureka Therapeutics is a biotechnology company that develops T-cell therapies.
Founded
obfuscation
PrivateGrant Emeryville, California, United States51-100 www.eurekatherapeutics.com
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Grant
OBF
in
obfuscation
Series E
OBF
in
obfuscation
Series D
OBF
in
obfuscation

Key People

Details

Legal Name Eureka Therapeutics, Inc.
Operating Status Active
Company Type For Profit
Founders  Cheng Liu
About the Company
Eureka Therapeutics is a biotechnology company that focuses on immunotherapies for the treatment of cancer. They have developed E-ALPHA into one of the world’s largest human-derived antibody phage libraries to generate target-specific antibodies, including T cell receptor-mimic antibodies against intracellular targets.
Phone Number +1 510 654 7045
Contact Email admin@eurekainc.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

ARTEMIS® Cell Receptor Platform
A proprietary technology designed to utilize T cells' natural biology to target and destroy cancer cells by engineering T cells to express ARTEMIS cell receptors.
E-ALPHA® Phage Display Platform
A drug discovery platform consisting of a large human-derived antibody phage library used to generate specific antibodies against cancer targets, including TCR-mimic antibodies for solid tumors.

Research & Development

Eureka Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 7
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant
obfuscation
Grant - Eureka Therapeutics Logo
Grant - Eureka Therapeutics
1
obfuscation
California Institute for Regenerative MedicineGrant

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 51-100 Employee Profiles 3 Board Members and Advisors 1 Contacts 45

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Nov 3, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

948
-73.03%
 in past month

IT Spend

$3.1MThis year, Eureka Therapeutics is projected to spend $3.1M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Apple iPad Logo
Apple iPad
96
Carve-Out Logo
Carve-Out
91
AI Literacy Logo
AI Literacy
89

Actively Used Products

12Eureka Therapeutics uses 12 technology products and services including HTML5, Facebook Comments, and  Google Analytics, according to G2 Stack.

Active Website Tech Count

5Eureka Therapeutics is actively using 5 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, HSTS, and  GoDaddy SSL.

Total IP

101The intellectual property of Eureka Therapeutics includes 93 registered patents primarily in the 'Organic Chemistry' category, according to IPqwery. Additionally, Eureka Therapeutics has registered 8 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Eureka Therapeutics's headquarters? Eureka Therapeutics is located in Emeryville, California, United States.Who invested in Eureka Therapeutics? Eureka Therapeutics has 9 investors including California Institute for Regenerative Medicine and  Lyell Immunopharma.When was the last funding round for Eureka Therapeutics? Eureka Therapeutics closed its last funding round on
obfuscation
from a Grant round.Who are Eureka Therapeutics's competitors? Alternatives and possible competitors to Eureka Therapeutics may include Gilead Sciences, Novartis, and  AstraZeneca.How much funding has Eureka Therapeutics raised to date? Eureka Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|